Keyphrases
Adverse Prognosis
100%
Allogeneic
20%
Body Burden
20%
Distant Site
20%
Endothelial Barrier
80%
Endothelial Monolayer
20%
Highly Active Antiretroviral Therapy (HAART)
20%
HIV Patients
20%
Human Immunodeficiency Virus Type 1 (HIV-1)
100%
Infected Cells
40%
Infected Leukocytes
20%
Infectious Virus
20%
Leukocyte Infiltrate
20%
Leukocytes
100%
Lymphoblast
20%
Peripheral Blood Mononuclear Leukocytes
20%
Phytohemagglutinin
20%
Reentry
20%
Reverse Migration
20%
Secondary Infection
20%
T Cells
40%
Transendothelial Migration
100%
Unselected Patients
20%
Viremia
20%
Virus
80%
Immunology and Microbiology
Back
14%
Human Immunodeficiency Virus
28%
Human Immunodeficiency Virus 1
100%
Leukocyte
100%
Lymphoblast
14%
Peripheral Blood Mononuclear Cell
14%
Phytohaemagglutinin
14%
T Cell
28%
Viremia
14%
Virus Infectivity
14%